Portable MRI maker Hyperfine's Q2 revenue rises less than expected

Hyperfine

06/08/2026 21:35

Overview
US portable MRI maker's Q2 revenue grew 45% yr/yr but missed analyst expectations
Net loss for Q2 widened slightly to $9.3 mln, loss per share was $0.09
Company maintained full-year guidance, expecting 55% revenue growth and lower cash burn

Outlook
Hyperfine expects 2026 revenue of $20 mln to $22 mln, unchanged from prior outlook
Company maintains 2026 cash burn guidance at $26 mln to $28 mln

Result Drivers
SYSTEM PLACEMENTS - Co said revenue growth was driven by increased placements of Swoop portable MRI systems in Q2
CLINICAL ADOPTION - Co cited record U.S. scan volume and expanding use across hospital and office settings as supporting broader adoption
INTERNATIONAL EXPANSION - Co pointed to regulatory approvals and initial sales in Europe as contributing to international commercial progress

Company press release: ID:nBw7n19tla

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Miss
$3.9 mln
$4.14 mln (3 Analysts)
Q2 Loss Per Share
 
$0.09
 
Q2 Net Loss
 
$9.3 mln
 
Q2 Operating Expenses
 
$10.45 mln
 
Q2 Operating Income
 
-$8.47 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Hyperfine Inc is $2.00, about 104.1% above its August 5 closing price of $0.98

Reuters Recommended Reads
Aug 5 - One Stop Systems Q2 revenue jumps on higher medical imaging sales; raises 2026 outlook
Aug 3 - ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Aug 4 - Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)